LLY

748.42

+1.7%↑

JNJ

177.03

-0.47%↓

ABBV

209.99

+0.36%↑

UNH

348.72

+8.76%↑

NVO

53.9

-0.77%↓

LLY

748.42

+1.7%↑

JNJ

177.03

-0.47%↓

ABBV

209.99

+0.36%↑

UNH

348.72

+8.76%↑

NVO

53.9

-0.77%↓

LLY

748.42

+1.7%↑

JNJ

177.03

-0.47%↓

ABBV

209.99

+0.36%↑

UNH

348.72

+8.76%↑

NVO

53.9

-0.77%↓

LLY

748.42

+1.7%↑

JNJ

177.03

-0.47%↓

ABBV

209.99

+0.36%↑

UNH

348.72

+8.76%↑

NVO

53.9

-0.77%↓

LLY

748.42

+1.7%↑

JNJ

177.03

-0.47%↓

ABBV

209.99

+0.36%↑

UNH

348.72

+8.76%↑

NVO

53.9

-0.77%↓

Search

Bausch Health Cos Inc

Abrir

SetorSaúde

7.21 -1.5

Visão Geral

Variação de preço das ações

24h

Atual

Mín

7.18

Máximo

7.33

Indicadores-chave

By Trading Economics

Rendimento

214M

128M

Vendas

277M

2.5B

P/E

Médio do Setor

28.539

35.733

EPS

0.607

Margem de lucro

5.112

Funcionários

20,700

EBITDA

636M

912M

Recomendações

By TipRanks

Recomendações

Neutro

Previsão para 12 meses

+13.64% upside

Dividendos

By Dow Jones

Próximos Ganhos

29 de out. de 2025

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

198M

2.7B

Abertura anterior

8.71

Fecho anterior

7.21

Sentimento de Notícias

By Acuity

50%

50%

173 / 371 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Strong Bearish Evidence

Bausch Health Cos Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

22 de abr. de 2025, 13:12 UTC

Aquisições, Fusões, Aquisições de Empresas

Bausch Health Learns Icahn Has 34% Economic Interest in Shares

17 de out. de 2024, 23:57 UTC

Ações em Alta

Stocks to Watch: Netflix, MGP Ingredients, Bausch Health

Comparação entre Pares

Variação de preço

Bausch Health Cos Inc Previsão

Preço-alvo

By TipRanks

13.64% parte superior

Previsão para 12 meses

Média 8.33 USD  13.64%

Máximo 10 USD

Mínimo 7 USD

Com base em 4 analistas de Wall Street que oferecem metas de preço de 12 meses para Bausch Health Cos Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Neutro

4 ratings

0

Comprar

4

Manter

0

Vender

Pontuação Técnica

By Trading Central

4.63 / 5.35Suporte e Resistência

Curto Prazo

Strong Bearish Evidence

Médio Prazo

Bearish Evidence

Longo Prazo

Bearish Evidence

Sentimento

By Acuity

173 / 371 Ranking em Saúde

Sentimento de Notícias

Neutral

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Abaixo da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Bausch Health Cos Inc

Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The Salix segment provides gastroenterology products in the United States. The International segment sells aesthetic medical devices, branded pharmaceuticals, generic pharmaceuticals, and OTC products internationally. The Solta Medical segment engages in the sale of aesthetic medical devices. The Diversified segment offers pharmaceutical products in the areas of neurology and certain other therapeutic classes; generic products; ortho dermatologic; and dentistry products in the United States. The Bausch + Lomb segment offers products in the areas of vision care, surgical, and ophthalmic pharmaceuticals products. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.
help-icon Live chat